chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; headache for approx 1 week; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (headache for approx 1 week) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter. No concomitant medication reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and HEADACHE (headache for approx 1 week). At the time of the report, PYREXIA (Fever) and HEADACHE (headache for approx 1 week) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Hypoaesthesia oral, Illness, Nausea
Clinical narrative: sick to the stomach; nausea; fever of 99.2°F to 99.6°F; very sick; mouth went numb; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), ABDOMINAL DISCOMFORT (sick to the stomach), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Coronavirus infection in November 2020. Concurrent medical conditions included Allergy to antibiotic (Cephalexin), Drug allergy (Any kind of -cain product (Novocain, lidocaine)) and Seafood allergy.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, the patient experienced ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F). On 23-Jul-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), ABDOMINAL DISCOMFORT (sick to the stomach), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jul-2021, Body temperature: 99.2°f to 99.6 (High) 99.2°F to 99.6°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: sick to the stomach; nausea; fever of 99.2°F to 99.6°F; very sick; mouth went numb; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), ABDOMINAL DISCOMFORT (sick to the stomach), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Coronavirus infection in November 2020. Concurrent medical conditions included Allergy to antibiotic (Cephalexin), Drug allergy (Any kind of -cain product (Novocain, lidocaine)) and Seafood allergy.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, the patient experienced ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F). On 23-Jul-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, ILLNESS (very sick), HYPOAESTHESIA ORAL (mouth went numb), ABDOMINAL DISCOMFORT (sick to the stomach), NAUSEA (nausea) and PYREXIA (fever of 99.2°F to 99.6°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jul-2021, Body temperature: 99.2°f to 99.6 (High) 99.2°F to 99.6°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose was missed 2 mos ago/ Son missed second Moderna dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose was missed 2 mos ago/ Son missed second Moderna dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose was missed 2 mos ago/ Son missed second Moderna dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose was missed 2 mos ago/ Son missed second Moderna dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported by reporter. No concomitant medications were reported by reporter.  The patient's parent asked if the patient need to start the second dose regimen again.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Heart rate increased, Tremor
Clinical narrative: Fast pulse/really fast pulse; Shaking really bad; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills). At the time of the report, HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported.  Treatment medication was not reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Confusional state, Cough, Oxygen saturation
Clinical narrative: Confusion; Unproductive cough/ Some Cough; A rash along neck; Low grade fever; Diagnosed with covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with covid), CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jul-2021 at 1:00 AM, the patient experienced COVID-19 (Diagnosed with covid). On an unknown date, the patient experienced CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) in July 2021 for Fever, at an unspecified dose and frequency and AMYLMETACRESOL, DICHLOROBENZYL ALCOHOL (ROBITUSSIN [AMYLMETACRESOL;DICHLOROBENZYL ALCOHOL]) in July 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (Diagnosed with covid), CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Body temperature: 101.8 f (High) low grade fever (highest recorded temperature). On 21-Jul-2021, Body temperature: 101.0 f (High) low grade fever. On 21-Jul-2021, Oxygen saturation: 92 (Inconclusive) 92 %. On 23-Jul-2021, Body temperature: 101.7 f (High) fever.   No relevant concomitant medications were provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Confusion; Unproductive cough/ Some Cough; A rash along neck; Low grade fever; Diagnosed with covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with covid), CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jul-2021 at 1:00 AM, the patient experienced COVID-19 (Diagnosed with covid). On an unknown date, the patient experienced CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) in July 2021 for Fever, at an unspecified dose and frequency and AMYLMETACRESOL, DICHLOROBENZYL ALCOHOL (ROBITUSSIN [AMYLMETACRESOL;DICHLOROBENZYL ALCOHOL]) in July 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (Diagnosed with covid), CONFUSIONAL STATE (Confusion), COUGH (Unproductive cough/ Some Cough), RASH (A rash along neck) and PYREXIA (Low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Body temperature: 101.8 f (High) low grade fever (highest recorded temperature). On 21-Jul-2021, Body temperature: 101.0 f (High) low grade fever. On 21-Jul-2021, Oxygen saturation: 92 (Inconclusive) 92 %. On 23-Jul-2021, Body temperature: 101.7 f (High) fever.   No relevant concomitant medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: Trouble sleeping after second shot; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Trouble sleeping after second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced INSOMNIA (Trouble sleeping after second shot). At the time of the report, INSOMNIA (Trouble sleeping after second shot) outcome was unknown.            Concomitant product information was not provided. Treatment information was not provided   Reporter did not allow further contact
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Road traffic accident
Clinical narrative: Got into an accident not long after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose). At the time of the report, ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.   This case was linked to MOD-2021-265617 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Tired a lot; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired a lot) and PAIN IN EXTREMITY (Pain in arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired a lot) and PAIN IN EXTREMITY (Pain in arm). At the time of the report, FATIGUE (Tired a lot) outcome was unknown and PAIN IN EXTREMITY (Pain in arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Cough, Dyspnoea
Clinical narrative: Patient received second shot beyond 42 day window period; Cough; fever; chills; Muscle aches; shortness of breath; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period) and COUGH (Cough) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic respiratory disease NOS since 2001.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period), COUGH (Cough), PYREXIA (fever), CHILLS (chills) and MYALGIA (Muscle aches). The patient was treated with BAMLANIVIMAB (intravenous) 21-Jan-2021 for COVID-19, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period), COUGH (Cough), PYREXIA (fever), CHILLS (chills) and MYALGIA (Muscle aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test: (Positive) positive.         This case was linked to MOD-2021-014458 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Patient received second shot beyond 42 day window period; Cough; fever; chills; Muscle aches; shortness of breath; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period) and COUGH (Cough) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic respiratory disease NOS since 2001.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period), COUGH (Cough), PYREXIA (fever), CHILLS (chills) and MYALGIA (Muscle aches). The patient was treated with BAMLANIVIMAB (intravenous) 21-Jan-2021 for COVID-19, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second shot beyond 42 day window period), COUGH (Cough), PYREXIA (fever), CHILLS (chills) and MYALGIA (Muscle aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test: (Positive) positive.         This case was linked to MOD-2021-014458 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: not feeling good, not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling good, not feeling well) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling good, not feeling well). At the time of the report, MALAISE (not feeling good, not feeling well) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second Dose not received in allowed time; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time). On 26-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: 2nd dose administered with a vial that had been punctured for more than 12 hours; 2nd dose administered more than 1 month after first; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Jul-2021 and was forwarded to Moderna on 26-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose administered with a vial that had been punctured for more than 12 hours) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered more than 1 month after first) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 006D21A) for COVID-19 vaccination.     Concomitant products included SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), TRAMADOL, ESCITALOPRAM OXALATE (LEXAPRO) and ALPRAZOLAM for an unknown indication.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose administered with a vial that had been punctured for more than 12 hours) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered more than 1 month after first). On 24-Jul-2021, EXPIRED PRODUCT ADMINISTERED (2nd dose administered with a vial that had been punctured for more than 12 hours) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered more than 1 month after first) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment drugs were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Batch number and Anatomical location provided for first dose.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A patient was administered 1st dose that was drawn and kept in refrigerator beyond 12 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Jul-2021 and was forwarded to Moderna on 26-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose that was drawn and kept in refrigerator beyond 12 hours) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose that was drawn and kept in refrigerator beyond 12 hours). On 25-Jul-2021, EXPIRED PRODUCT ADMINISTERED (A patient was administered 1st dose that was drawn and kept in refrigerator beyond 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided  Treatment information was not provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Peripheral swelling, Pyrexia
Clinical narrative: Swollen arm; Fever (100.3°F); This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and PYREXIA (Fever (100.3°F)) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm) and PYREXIA (Fever (100.3°F)). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and PYREXIA (Fever (100.3°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.3 (High) 100.3 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Glaucoma medication (unspecified). No treatment medications were not provided.  The patient believed about not having fever anymore during the time of call.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Product dose omission issue
Clinical narrative: Missed second scheduled Moderna Dose (>42 days); dizziness; This spontaneous case was reported by a pharmacist and describes the occurrence of DIZZINESS (dizziness) and PRODUCT DOSE OMISSION ISSUE (Missed second scheduled Moderna Dose (>42 days)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second scheduled Moderna Dose (>42 days)). At the time of the report, DIZZINESS (dizziness) and PRODUCT DOSE OMISSION ISSUE (Missed second scheduled Moderna Dose (>42 days)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Inflammation, Rash
Clinical narrative: chest pain; inflammation of the same as a rash all over the body; inflammation of the same as a rash all over the body; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Jul-2021 and was forwarded to Moderna on 26-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), INFLAMMATION (inflammation of the same as a rash all over the body) and RASH (inflammation of the same as a rash all over the body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), INFLAMMATION (inflammation of the same as a rash all over the body) and RASH (inflammation of the same as a rash all over the body). At the time of the report, CHEST PAIN (chest pain), INFLAMMATION (inflammation of the same as a rash all over the body) and RASH (inflammation of the same as a rash all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medication was provided. No concomitant treatment was provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: Fatigue; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Product dose omission issue
Clinical narrative: heartbeat in his head; headaches ever since his first dose/throbbing; Only received one dose, Patient did not receive his second dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Only received one dose, Patient did not receive his second dose.), HEAD DISCOMFORT (heartbeat in his head) and HEADACHE (headaches ever since his first dose/throbbing) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Only received one dose, Patient did not receive his second dose.). On an unknown date, the patient experienced HEAD DISCOMFORT (heartbeat in his head) and HEADACHE (headaches ever since his first dose/throbbing). On 09-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Only received one dose, Patient did not receive his second dose.) had resolved. At the time of the report, HEAD DISCOMFORT (heartbeat in his head) and HEADACHE (headaches ever since his first dose/throbbing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  The patient received steroid drug as a treatment medication.  It was reported that ever since the patient received his first dose of vaccine he constantly getting headaches, like throbbing headaches, which got worsed when he was outside, It was painful.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Myalgia, Peripheral swelling, Vaccination site reaction
Clinical narrative: covid arm; swollen arm; hot to touch; red down my arm, extreme pin all down my arm into my fingers; sore arm, extreme pin all down my arm into my fingers; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Jul-2021 and was forwarded to Moderna on 26-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), PERIPHERAL SWELLING (swollen arm), FEELING HOT (hot to touch), ERYTHEMA (red down my arm, extreme pin all down my arm into my fingers) and MYALGIA (sore arm, extreme pin all down my arm into my fingers) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm), PERIPHERAL SWELLING (swollen arm), FEELING HOT (hot to touch), ERYTHEMA (red down my arm, extreme pin all down my arm into my fingers) and MYALGIA (sore arm, extreme pin all down my arm into my fingers). At the time of the report, VACCINATION SITE REACTION (covid arm), PERIPHERAL SWELLING (swollen arm), FEELING HOT (hot to touch), ERYTHEMA (red down my arm, extreme pin all down my arm into my fingers) and MYALGIA (sore arm, extreme pin all down my arm into my fingers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Feel a little tired and worn out; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feel a little tired and worn out) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Feel a little tired and worn out). At the time of the report, FATIGUE (Feel a little tired and worn out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient vaccinated 19 hours after vaccine was drawn up and refrigerated; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient vaccinated 19 hours after vaccine was drawn up and refrigerated) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, Chronic respiratory failure, COPD, Type 2 diabetes mellitus and Liver cirrhosis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient vaccinated 19 hours after vaccine was drawn up and refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient vaccinated 19 hours after vaccine was drawn up and refrigerated) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Administered three doses today - after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jul-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: heart pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (heart pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (heart pain). At the time of the report, CHEST PAIN (heart pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications are provided. Treatment to the events not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling hot, Induration, Myalgia
Clinical narrative: hardness; Feeling of warmth; redness; chills; feverish; arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills) and PYREXIA (feverish) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included ATORVASTATIN and HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills), PYREXIA (feverish) and MYALGIA (arm was very sore). At the time of the report, INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills), PYREXIA (feverish) and MYALGIA (arm was very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: hardness; Feeling of warmth; redness; chills; feverish; arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills) and PYREXIA (feverish) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included ATORVASTATIN and HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills), PYREXIA (feverish) and MYALGIA (arm was very sore). At the time of the report, INDURATION (hardness), FEELING HOT (Feeling of warmth), ERYTHEMA (redness), CHILLS (chills), PYREXIA (feverish) and MYALGIA (arm was very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm became sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm became sore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm became sore). At the time of the report, PAIN IN EXTREMITY (Arm became sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient arm became sore. No concomitant medications were provided. Treatment medications were unknown.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Jul-2021 and was forwarded to Moderna on 26-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not reported. Patient reported of heartbeat getting high on an unknown date and unknown outcome. Further details were not reported. Treatment medications was not reported.   Reporter did not allow further contact
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left injection site arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore left injection site arm). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) (nasal) ongoing since an unknown date at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency; AMOXICILLIN ongoing since an unknown date at an unspecified dose and frequency; PREDNISONE ongoing since an unknown date at an unspecified dose and frequency and ALBUTEROL [SALBUTAMOL] ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Sore left injection site arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative and negative (Negative) negative.     No relevant concomitant medications were reported.  The patient was exposed to someone who has Covid-19 and he feels like the patient had Covid-19.The patient had gone to Urgent Care and prescribed with Flonase nasal spray, Zyrtec, Amoxicillin, Prednisone and Albuterol Inhaler.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-266012 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: More than 36 days after the first dose without receiving the second dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE), BUPROPION and NICOTINE for an unknown indication.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Vision blurred
Clinical narrative: large bruises on the right tight; little blurred vision; feel a little bit loopy, not a totally dizzy but loopy.; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (large bruises on the right tight), VISION BLURRED (little blurred vision) and DIZZINESS (feel a little bit loopy, not a totally dizzy but loopy.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL (CARDINAL), LISINOPRIL and DOPAMINE for an unknown indication.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (large bruises on the right tight), VISION BLURRED (little blurred vision) and DIZZINESS (feel a little bit loopy, not a totally dizzy but loopy.). At the time of the report, CONTUSION (large bruises on the right tight), VISION BLURRED (little blurred vision) and DIZZINESS (feel a little bit loopy, not a totally dizzy but loopy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: unrelated issue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (unrelated issue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (unrelated issue). At the time of the report, VACCINATION COMPLICATION (unrelated issue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medication were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: More than 36 days since the first shot/ never got the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days since the first shot/ never got the second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included COVID-19 in October 2020. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days since the first shot/ never got the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days since the first shot/ never got the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment was received by the patient.